BTI
IRWD icon

Blue Trust Inc’s Ironwood Pharmaceuticals IRWD Stock Holding History

Blue Trust Inc’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$119 Hold
34
– – ﹤0.01% 2445
2025
Q4 		$115 Hold
34
– – ﹤0.01% 2497
2025
Q3 		$45 Hold
34
– – ﹤0.01% 2549
2025
Q2 		$24 Hold
34
– – ﹤0.01% 2435
2025
Q1 		$50 Buy
+34
New +$81 ﹤0.01% 2454
2023
Q2 		– Sell
-2,264
Closed -$28K – 2282
2023
Q1 		$28K Sell
2,264
-2,594
-53% -$29.1K ﹤0.01% 1254
2022
Q4 		$50K Buy
4,858
+4,832
+18,585% +$54.8K ﹤0.01% 917
2022
Q3 		$0 Hold
26
– – ﹤0.01% 2205
2022
Q2 		$0 Buy
+26
New +$306 ﹤0.01% 1943

Other funds holding IRWD

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Blue Trust Inc's IRWD Position: Q1 2026 in Review

Blue Trust Inc held its Ironwood Pharmaceuticals (IRWD) position steady in Q1 2026 at 34 shares worth $119. The position accounts for ﹤0.01% of the portfolio, ranked #2445.

Blue Trust Inc first reported a position in IRWD in Q2 2022 and has held it in 9 quarters since. The position peaked at $50K in Q4 2022. 226 funds tracked by Wall St. Rank hold IRWD as of Q1 2026.

  • Blue Trust Inc held 34 shares of Ironwood Pharmaceuticals worth $119 as of Q1 2026.
  • Blue Trust Inc left its Ironwood Pharmaceuticals share count unchanged in Q1 2026.
  • Ironwood Pharmaceuticals made up ﹤0.01% of Blue Trust Inc's portfolio in Q1 2026, its #2445 holding.
  • Blue Trust Inc first reported a position in Ironwood Pharmaceuticals in Q2 2022 and has held it in 9 quarters since.
  • Blue Trust Inc's Ironwood Pharmaceuticals position peaked at $50K in Q4 2022.
  • 226 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2026.

Based on Blue Trust Inc's 13F filing for Q1 2026, filed 20 Apr 2026.